In our study, an increasing trend of prescription of these novel medications can be observed in all groups with and without cirrhosis, although the safety was not fully proven in the decompensated cirrhosis group.
← all excerpts
Secular Trend in Glycaemic Management in Type 2 Diabetes Patients With and Without Cirrhosis Between 2000 and 2023: A Territory-Wide Cohort Study.
1
—
—